Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.
AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda ...
By Kamal Choudhury Feb 9 (Reuters) - Privately held Iambic said on Monday it has entered a multi-year partnership worth more ...
After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...
The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
Insilico Medicine (“Insilico”, 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
At Sanofi, AI has shifted from experimentation to becoming a vital part of our infrastructure.
GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial ...
Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results